• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树突状细胞代谢:提高抗肿瘤树突状细胞疫苗接种的战略途径。

Dendritic cells metabolism: a strategic path to improve antitumoral DC vaccination.

机构信息

School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin, 2, Ireland.

School of Pharmacy and Pharmaceutical Sciences, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin, 2, Ireland.

出版信息

Clin Exp Immunol. 2022 Jun 11;208(2):193-201. doi: 10.1093/cei/uxac048.

DOI:10.1093/cei/uxac048
PMID:35537194
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9188343/
Abstract

The critical role developed by dendritic cell (DC) in the orchestration of immune response explains its exploitation in different therapeutic approaches as potential vaccine tools. Various clinical trials dissect its role in different types of solid cancers. However, there is a lack of comprehension regarding the potential impact of DC metabolic pathways on the effectiveness of DC vaccine. In this review, we intend to dissect how metabolism could be a critical component of DC vaccine formulation, exploring opportunities to improve: (i) processing and cross-presentation of tumour antigens; (ii) DC migration, and (iii) DC immunogenic profile. Overall, we aim to open the discussion to explore new avenues/paths where DC metabolism might be considered a core component of antitumour DC vaccine with this review.

摘要

树突状细胞 (DC) 在免疫反应调控中发挥的关键作用解释了其在不同治疗方法中被用作潜在疫苗工具的原因。各种临床试验分析了其在不同类型实体瘤中的作用。然而,人们对 DC 代谢途径对 DC 疫苗有效性的潜在影响缺乏理解。在这篇综述中,我们旨在剖析代谢如何成为 DC 疫苗配方的关键组成部分,探索改善的机会:(i) 肿瘤抗原的加工和交叉呈递;(ii) DC 迁移;以及 (iii) DC 免疫原性特征。总的来说,我们旨在展开讨论,探索新的途径/路径,在这些途径/路径中,DC 代谢可能被视为抗肿瘤 DC 疫苗的核心组成部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ca/9188343/2877547838fe/uxac048f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ca/9188343/2877547838fe/uxac048f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ca/9188343/2877547838fe/uxac048f0004.jpg

相似文献

1
Dendritic cells metabolism: a strategic path to improve antitumoral DC vaccination.树突状细胞代谢:提高抗肿瘤树突状细胞疫苗接种的战略途径。
Clin Exp Immunol. 2022 Jun 11;208(2):193-201. doi: 10.1093/cei/uxac048.
2
DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice.针对树突状细胞编码抗原的 DNA 疫苗可在小鼠中诱导强烈的抗肿瘤免疫。
BMC Immunol. 2013 Aug 14;14:39. doi: 10.1186/1471-2172-14-39.
3
Immature dendritic cell/tumor cell fusions induce potent antitumour immunity.未成熟树突状细胞/肿瘤细胞融合体可诱导强大的抗肿瘤免疫力。
Eur J Clin Invest. 2003 Oct;33(10):897-904. doi: 10.1046/j.1365-2362.2003.01194.x.
4
Antitumour dendritic cell vaccination in a priming and boosting approach.树突状细胞瘤苗接种在初步免疫和加强免疫中的应用。
Nat Rev Drug Discov. 2020 Sep;19(9):635-652. doi: 10.1038/s41573-020-0074-8. Epub 2020 Aug 6.
5
Dendritic cell fusion vaccines for cancer immunotherapy.用于癌症免疫治疗的树突状细胞融合疫苗。
Expert Opin Biol Ther. 2005 May;5(5):703-15. doi: 10.1517/14712598.5.5.703.
6
Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.白细胞介素-15/白细胞介素-15受体α信使核糖核酸工程化人树突状细胞对白细胞介素-15的转递呈递增强了抗肿瘤自然杀伤细胞活性。
Oncotarget. 2015 Dec 29;6(42):44123-33. doi: 10.18632/oncotarget.6536.
7
Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma.树突状细胞/肿瘤细胞融合杂交体疫苗对小鼠lewis 肺癌的抗肿瘤保护和治疗效果更优。
Autoimmunity. 2014 Feb;47(1):46-56. doi: 10.3109/08916934.2013.850080. Epub 2013 Nov 5.
8
Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results.个性化树突状细胞疫苗 - 最新突破和鼓舞人心的临床结果。
Front Immunol. 2019 Apr 11;10:766. doi: 10.3389/fimmu.2019.00766. eCollection 2019.
9
Dendritic cell vaccination in melanoma patients: From promising results to future perspectives.黑色素瘤患者的树突状细胞疫苗接种:从有前景的结果到未来展望。
Hum Vaccin Immunother. 2016 Oct 2;12(10):2523-2528. doi: 10.1080/21645515.2016.1197453. Epub 2016 Jun 20.
10
Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity.用外泌体脉冲处理的成熟树突状细胞可刺激有效的细胞毒性T淋巴细胞反应和抗肿瘤免疫。
Immunology. 2007 Jan;120(1):90-102. doi: 10.1111/j.1365-2567.2006.02483.x. Epub 2006 Oct 31.

引用本文的文献

1
Elevated glycolytic metabolism of monocytes limits the generation of HIF1A-driven migratory dendritic cells in tuberculosis.单核细胞糖酵解代谢升高限制了结核分枝杆菌中 HIF1A 驱动的迁移树突状细胞的生成。
Elife. 2024 Jun 26;12:RP89319. doi: 10.7554/eLife.89319.
2
Perspective view of allogeneic IgG tumor immunotherapy.同种异体IgG肿瘤免疫疗法的透视图。
Cancer Cell Int. 2024 Mar 9;24(1):100. doi: 10.1186/s12935-024-03290-9.
3
Dendritic cells as orchestrators of anticancer immunity and immunotherapy.树突状细胞作为抗癌免疫和免疫治疗的协调者。

本文引用的文献

1
Plasmacytoid dendritic cell activation is dependent on coordinated expression of distinct amino acid transporters.浆细胞样树突状细胞的激活依赖于不同氨基酸转运体的协调表达。
Immunity. 2021 Nov 9;54(11):2514-2530.e7. doi: 10.1016/j.immuni.2021.10.009. Epub 2021 Oct 29.
2
Metabolic programming in dendritic cells tailors immune responses and homeostasis.树突状细胞代谢编程调节免疫反应和稳态。
Cell Mol Immunol. 2022 Mar;19(3):370-383. doi: 10.1038/s41423-021-00753-1. Epub 2021 Aug 19.
3
Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors.
Nat Rev Clin Oncol. 2024 Apr;21(4):257-277. doi: 10.1038/s41571-024-00859-1. Epub 2024 Feb 7.
4
Natural polysaccharides exert anti-tumor effects as dendritic cell immune enhancers.天然多糖作为树突状细胞免疫增强剂发挥抗肿瘤作用。
Front Oncol. 2023 Oct 9;13:1274048. doi: 10.3389/fonc.2023.1274048. eCollection 2023.
5
Vaccine adjuvants to engage the cross-presentation pathway.疫苗佐剂以激活交叉呈递途径。
Front Immunol. 2022 Aug 1;13:940047. doi: 10.3389/fimmu.2022.940047. eCollection 2022.
6
Metabolites: fuelling the immune response.代谢物:为免疫反应提供能量。
Clin Exp Immunol. 2022 Jun 11;208(2):129-131. doi: 10.1093/cei/uxac053.
他汀类药物作为瞬时 I 型干扰素抑制剂,使改良安卡拉痘苗病毒载体具有抗肿瘤活性。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2020-001587.
4
The lysosomal Ragulator complex plays an essential role in leukocyte trafficking by activating myosin II.溶酶体 Ragulator 复合物通过激活肌球蛋白 II 在白细胞运输中发挥重要作用。
Nat Commun. 2021 Jun 7;12(1):3333. doi: 10.1038/s41467-021-23654-3.
5
Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity.分泌型凝胶蛋白抑制 DNGR-1 依赖性交叉呈递和癌症免疫。
Cell. 2021 Jul 22;184(15):4016-4031.e22. doi: 10.1016/j.cell.2021.05.021. Epub 2021 Jun 2.
6
DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.DNGR-1 通过限制肿瘤浸润性 I 型常规树突状细胞来限制 Flt3L 介导的抗肿瘤免疫。
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2020-002054.
7
Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy.肿瘤微环境中树突状细胞的代谢:用于免疫治疗。
Front Immunol. 2021 Feb 24;12:613492. doi: 10.3389/fimmu.2021.613492. eCollection 2021.
8
The Mevalonate Pathway, a Metabolic Target in Cancer Therapy.甲羟戊酸途径,癌症治疗中的一个代谢靶点。
Front Oncol. 2021 Feb 25;11:626971. doi: 10.3389/fonc.2021.626971. eCollection 2021.
9
Dendritic Cells Revisited.树突状细胞再探。
Annu Rev Immunol. 2021 Apr 26;39:131-166. doi: 10.1146/annurev-immunol-061020-053707. Epub 2021 Jan 22.
10
Role of dendritic cell metabolic reprogramming in tumor immune evasion.树突状细胞代谢重编程在肿瘤免疫逃逸中的作用。
Int Immunol. 2020 Jun 26;32(7):485-491. doi: 10.1093/intimm/dxaa036.